2019
DOI: 10.1016/s2468-1253(19)30246-8
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis

Abstract: This is a repository copy of Efficacy of drugs in chronic idiopathic constipation: a systematic review and network meta-analysis.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
88
1
6

Year Published

2019
2019
2024
2024

Publication Types

Select...
6
2
1
1

Relationship

3
7

Authors

Journals

citations
Cited by 96 publications
(101 citation statements)
references
References 64 publications
6
88
1
6
Order By: Relevance
“…Strategies were ranked according to their surface under the cumulative ranking curve value, which is comparable to the P score used in the frequentist model of our primary analyses 37. There were no differences in rankings among approaches, and therefore, for clarity, we only report the frequentist model in this paper, which is consistent with our approach for reporting previously published network meta-analyses 4041424344…”
Section: Methodsmentioning
confidence: 65%
“…Strategies were ranked according to their surface under the cumulative ranking curve value, which is comparable to the P score used in the frequentist model of our primary analyses 37. There were no differences in rankings among approaches, and therefore, for clarity, we only report the frequentist model in this paper, which is consistent with our approach for reporting previously published network meta-analyses 4041424344…”
Section: Methodsmentioning
confidence: 65%
“…We did not include shamcontrolled trials of any of these interventions, due to potential differences in the sham procedure, depending on the active intervention used, meaning that these could not be treated as a single comparator, as would be the case in a network meta-analysis of placebo-controlled drug trials. [24][25][26][27] We also did not include trials that compared the above interventions against Botox therapy, as this would potentially introduce a selection bias for patients, due to the higher likelihood of the inclusion of comorbid patients, who would not be considered fit enough for either POEM or LHM, in such trials.…”
Section: Search Strategy and Selection Criteriamentioning
confidence: 99%
“…Проносні засобице препарати з різним механізмом дії для лікування або попередження закрепів, ефективність яких підтверджена у низці досліджень та метааналізів [9,23,30]. Закрепглобальна проблема, яку населення, зазвичай, самостійно діагностує та успішно лікує [12,14,32,35].…”
Section: вступunclassified